These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9250900)

  • 1. Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.
    Ikeda K; Saitoh S; Suzuki Y; Tsubota A; Koida I; Kobayashi M; Arase Y; Chayama K; Murashima N; Kumada H
    J Gastroenterol; 1997 Aug; 32(4):513-20. PubMed ID: 9250900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K; Saitoh S; Kumada H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
    Maeda H
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.
    Tashiro S; Maeda H
    Jpn J Med; 1985 Feb; 24(1):79-80. PubMed ID: 2987585
    [No Abstract]   [Full Text] [Related]  

  • 5. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.
    Seymour LW; Olliff SP; Poole CJ; De Takats PG; Orme R; Ferry DR; Maeda H; Konno T; Kerr DJ
    Int J Oncol; 1998 Jun; 12(6):1217-23. PubMed ID: 9592177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple hepatic infarction after transcatheter arterial infusion with SMANCS.
    Abe S; Yamasaki T; Nakano K; Yoshikawa I; Tabaru A; Otsuki M
    J Gastroenterol; 2001 Jun; 36(6):415-21. PubMed ID: 11428589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal therapeutic efficacy of transcatheter arterial infusion of styrene maleic acid neocarzinostatin for hepatocellular carcinoma.
    Abe S; Okubo Y; Ejiri Y; Kume K; Otsuki M
    J Gastroenterol; 2000; 35(1):28-33. PubMed ID: 10632537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
    Yamasaki K; Konno T; Miyauchi Y; Maeda H
    Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
    Maki S; Konno T; Iwai K; Uchida M; Tashiro S; Miyauchi Y; Maeda H
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1443-9. PubMed ID: 6097616
    [No Abstract]   [Full Text] [Related]  

  • 13. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
    Okusaka T; Okada S; Ishii H; Ikeda M; Nakasuka H; Nagahama H; Iwata R; Furukawa H; Takayasu K; Nakanishi Y; Sakamoto M; Hirohashi S; Yoshimori M
    Oncology; 1998; 55(4):276-83. PubMed ID: 9663415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S; Otsuki M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
    Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
    Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
    Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N
    Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
    Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
    Tsuchiya K; Uchida T; Kobayashi M; Maeda H; Konno T; Yamanaka H
    Urology; 2000 Apr; 55(4):495-500. PubMed ID: 10736490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.